SIA "FuturaPharm"Active
Key figures
Ratios
2025Balance sheet structure
Summary of financial statements2015–2025
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||
| Total current assets | 2472 | 2354 | 673 | 580 | 487 | 394 | 299 | 199 | 215 | 30 996 | 19 484 |
| Total non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 000 | 9600 | 8434 |
| Total assets | 2472 | 2354 | 673 | 580 | 487 | 394 | 299 | 199 | 12 215 | 40 596 | 27 918 |
| Balance sheet — liabilities and equity | |||||||||||
| Current liabilities | 765 | 719 | 814 | 814 | 814 | 815 | 815 | 814 | 5126 | 22 795 | 32 151 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 700 | 35 200 | 96 170 |
| Total liabilities | 765 | 719 | 814 | 814 | 814 | 815 | 815 | 814 | 18 826 | 57 995 | 128 321 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | -1093 | -72 | -1776 | -93 | -93 | -94 | -95 | -99 | -5996 | -57 988 | -83 005 |
| Total equity | 1707 | 1635 | -141 | -234 | -327 | -421 | -516 | -615 | -6611 | -17 399 | -100 403 |
| Income statement | |||||||||||
| Sales revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46 116 | 94 757 |
| Operating profit | -1043 | -22 | -1726 | -43 | -43 | -44 | -45 | -49 | -5930 | -55 758 | -79 251 |
| Profit before income tax | -1043 | -22 | -1726 | -43 | -43 | -44 | -45 | -49 | -5996 | -57 542 | -83 005 |
| Profit for the reporting year | -1093 | -72 | -1776 | -93 | -93 | -94 | -95 | -99 | -5996 | -57 988 | -83 005 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 3 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
- SIA "Sendito" — 3 shared people
- SIA "Klīnika Piramīda 3" — 2 shared people
- Sabiedrība ar ierobežotu atbildību "Arvels" — 2 shared people
- Dzīvokļu īpašnieku kooperatīvā sabiedrība "SERVISS 306"
- SIA "Kalnciema 27"
- SIA "Lat Assist"
- SIA "Med4U"
- SIA "Noto"
- Sabiedrība ar ierobežotu atbildību "ALFA NAMI"
- Sabiedrība ar ierobežotu atbildību "HS Projekti"
- Sporta klubs "Modernā pieccīņa"
Summary: SIA "FuturaPharm"
Overview
SIA "FuturaPharm" (reg. no. 40103828862) is a limited liability company. The company was registered in 2014 and has been in the register for 12 years. Registered address: Rīga, Kalnciema iela 27 - 1.
Financial results
Revenue in 2025 was 94 757 €, up 105% on the previous year (46 116 €). This is the company's highest revenue among the published years (2015–2025). 2025 ended with a loss of 83 005 €. The company made a loss in all 11 published years. In 2025 the company had 3 employees. Revenue per employee was 31 586 €.
Management and owners
The board has 2 members. According to the register, the company has 5 owners. The largest stake (55%) is held by SIA "Klīnika Piramīda 3".
Points to note
Equity was negative at the end of 2025 (-100 403 €).
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.